Holding, Stress, and Bonding During Therapeutic Hypothermia
The Effects of Holding on Stress and Bonding in Mother-Infant Dyads During Therapeutic Hypothermia
1 other identifier
interventional
10
1 country
1
Brief Summary
Ten infants undergoing therapeutic hypothermia for hypoxic-ischemic encephalopathy will be enrolled in a new protocol that will allow mothers to hold their infants during the hypothermia treatment period. This is a safety study that will assess whether or not there is an increase in adverse event frequency in infants that are held during hypothermia. Parents and NICU nurses will be given a questionnaire after holding is complete investigating their feelings on maternal-infant bonding and safety of the holding protocol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 6, 2017
CompletedFirst Posted
Study publicly available on registry
March 14, 2017
CompletedStudy Start
First participant enrolled
March 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 23, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 23, 2017
CompletedResults Posted
Study results publicly available
January 26, 2022
CompletedSeptember 4, 2025
August 1, 2025
6 months
March 6, 2017
May 29, 2019
August 22, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Frequency of Adverse Events (Safety)
Assess the frequency of adverse events during the holding intervention including unintentional rewarming of the infant, dislodged infant catheters (umbilical arterial/venous lines, urinary catheter, iv) or infant intolerance of holding due to vital sign instability.
3 days
Secondary Outcomes (13)
Qualitative Experience of Mothers: Before I Could Hold my Baby, I Would Describe Our Ability to Bond as:
3 days
Qualitative Experience of Mothers: After Holding my Baby, I Feel Our Bond is:
3 days
Qualitative Experience of Mothers: Before Holding my Baby, my Stress Level Was:
3 days
Qualitative Experience of Mothers: After Holding my Baby, I Feel:
3 days
Qualitative Experience of Mothers: I am Glad I Had the Opportunity to Hold my Baby During Treatment With Hypothermia
3 days
- +8 more secondary outcomes
Study Arms (1)
Holding Group
EXPERIMENTALAfter meeting inclusion criteria and consenting to participation, mothers of infants who have completed at least 24 hours of therapeutic hypothermia treatment will be allowed to hold their infant who will remain on the cooling blanket for a 30-minute period with the use of a thermal barrier. Vital signs will be measured before holding begins, during holding and following completion of holding. Temperature will be recorded every two minutes during holding. Afterwards, a Likert scale questionnaire to assess the mother's and nurse's reactions will be administered.
Interventions
An initial set of vital sings will be recorded before the infant is removed from the isolette. The mother will sit in a reclining chair next to the isolette and place a thermal barrier over her chest and abdomen. The infant will be transferred to the mother by placing the hands under the cooling blanket so as to move the infant and cooling blanket together as one unit. The mother will be allowed to hold for thirty minutes provided that the infant's temperature does not increase by greater than one degree centigrade and the oxygen saturation does not drop below 90%. After thirty minutes, the infant will be returned to the isolette.
Eligibility Criteria
You may qualify if:
- Infant must have a gestational age of greater than or equal to 35 weeks
- Infant must be undergoing treatment with therapeutic hypothermia
- Infant must be without seizures in the first 24 hours of treatment based on EEG
- Infant must be clinically stable on bubble CPAP, nasal cannula, or no respiratory support.
- Informed consent must be signed by the mother at Maine Medical Center
You may not qualify if:
- Infant is intubated
- Infant is being treated with inhaled nitric oxide
- Presence of Persistent Pulmonary Hypertension of the Newborn
- Presence of seizure on EEG
- Use of vasopressors or paralytic agents
- Presence of chest tubes, wound vacuums, or drains
- Neonatal abstinence syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Alexa Craiglead
- MaineHealthcollaborator
Study Sites (1)
Maine Medical Center
Portland, Maine, 04102, United States
Related Publications (1)
Craig A, Deerwester K, Fox L, Jacobs J, Evans S. Maternal holding during therapeutic hypothermia for infants with neonatal encephalopathy is feasible. Acta Paediatr. 2019 Sep;108(9):1597-1602. doi: 10.1111/apa.14743. Epub 2019 Mar 5.
PMID: 30721531DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Alexa Craig
- Organization
- Maine Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Alexa Craig, MD, MSc
MaineHealth
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor of Pediatrics
Study Record Dates
First Submitted
March 6, 2017
First Posted
March 14, 2017
Study Start
March 20, 2017
Primary Completion
September 23, 2017
Study Completion
September 23, 2017
Last Updated
September 4, 2025
Results First Posted
January 26, 2022
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share